Patient no.# | BLM dose mg | Lung score | Lung responder score¶ | HLA-DRB1* | TNF-308 | TNFa | |
Total | Per week | ||||||
1 | 30 | 4.2 | 4 | 13.3 | 15/11 | 1/1 | 2/11 |
2+ | 30 | 10.0 | 4 | 13.3 | 15/x | 1/1 | 2/6 |
3 | 30 | 8.8 | 3 | 10.0 | 04/11 | 1/1 | 2/9 |
4 | 60 | 6.0 | 4 | 6.6 | 03/01 | 1/2 | 2/11 |
5 | 45 | 5.2 | 3 | 6.6 | 03/11 | 1/2 | 2/2 |
6 | 45 | 5.2 | 3 | 6.6 | 04/11 | 1/1 | 6/11 |
7 | 45 | 11.0 | 3 | 6.6 | 01/04 | 1/1 | 6/10 |
8 | 45 | 5.2 | 3 | 6.6 | 15/03 | 1/1 | 2/9 |
9 | 45 | 10.0 | 2 | 4.4 | 15/01 | 1/1 | 6/11 |
10 | 90 | 4.0 | 4 | 4.4 | 15/11 | 1/1 | 7/10 |
11 | 90 | 4.5 | 4 | 4.4 | 15/x | 1/2 | 2/11 |
12 | 105 | 2.7 | 4 | 3.8 | 03/13 | 1/1 | 2/10 |
13 | 110 | 5.2 | 4 | 3.8 | 16/03 | 1/2 | 2/10 |
14 | 120 | 6.0 | 4 | 3.3 | 15/04 | 1/1 | 2/10 |
15 | 105 | 1.9 | 4 | 3.8 | 11/x | 1/1 | 4/5 |
16 | 30 | 6.0 | 1 | 3.3 | 11/01 | 1/1 | 2/6 |
17 | 110 | 6.0 | 4 | 3.3 | 01/15 | 1/1 | 5/9 |
18 | 90 | 9.0 | 3 | 3.3 | 01/15 | 1/1 | 6/10 |
19 | 105 | 12.2 | 3 | 2.8 | 03/16 | 1/2 | 2/6 |
20 | 120 | 2.8 | 3 | 2.5 | 15/07 | 1/2 | 2/6 |
21+ | 210 | 5.0 | 4 | 1.9 | 03/11 | 1/1 | 2/4 |
22 | 120 | 15.0 | 2 | 1.6 | 16/01 | 1/2 | 4/11 |
23 | 90 | 4.5 | 1 | 1.1 | 07/11 | 1/1 | 7/10 |
24 | 105 | 13.0 | 1 | 1.0 | 03/10 | 1/1 | 9/11 |
25 | 105 | 5.0 | 1 | 1.0 | 04/13 | 1/1 | 2/6 |
26 | 90 | 4.2 | 1 | 1.1 | 03/04 | 1/1 | 10/11 |
27 | 120 | 4.0 | 1 | <1 | 04/07 | 1/1 | 7/14 |
28+ | 120 | 4.2 | 1 | <1 | 13/04 | 1/1 | 4/7 |
29 | 150 | 4.3 | 1 | <1 | 01/x | 1/2 | 5/7 |
30 | 135 | 7.6 | 0 | <1 | 15/x | 1/1 | 4/10 |
31 | 45 | 6.3 | 0 | <1 | 16/11 | 1/1 | 5/6 |
32 | 105 | 4.1 | 0 | <1 | 12/13 | 1/1 | 11/12 |
33 | 90 | 5.8 | 0 | <1 | 03/16 | 2/2 | 2/4 |
34 | 30 | 2.9 | 0 | <1 | 11/x | 1/1 | 10/10 |
35 | 30 | 4.0 | 0 | <1 | 01/11 | 1/1 | 6/9 |
36 | 45 | 5.0 | 0 | <1 | 16/11 | 1/1 | 3/10 |
37 | 45 | 5.2 | 0 | <1 | 11/14 | 1/1 | 10/11 |
38 | 509 | 8.7 | 4 | <1 | 16/11 | 1/1 | 10/10 |
39 | 90 | 4.5 | 0 | <1 | 15/04 | 1/1 | 2/8 |
40 | 120 | 5.7 | 0 | <1 | 15/10 | 1/1 | 9/11 |
41 | 225 | 8.0 | 0 | <1 | 01/07 | 1/1 | 4/7 |
BLM: Bleomycin
#: patients were treated with GHT associated with radiotherapy
¶: patients were ranked according to the lung responder score
+: patients were treated with chemotherapy alone